Clobetasol propionate 0. 05% solution

Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest special notice from .

Solicitation number
SPE2D218R0018
Agency
Responses due
Not on record
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

LEVALBUTEROL HCL SOLUTION NATIONAL CONTRACT

Update #1 ·

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Clobetasol Propionate 0.5% Topical Solution. Procurement details follow.

Clobetasol Propionate 0.5% Topical Solution in 25ML and 50ML bottles. . This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and FEDBIZOPS at https://www.fbo.gov. Interested parties should contact Denise Taubman (215)737-8677 denise.taubman@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is January of 2018. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Files

File Type Posted
Signed SPE2D218D0058 P00007.PDF PDF
SPE2D218D0058_P00006.pdf PDF
SPE2D218D0058P00005_Signed.pdf PDF
SPE2D218D0058P00004.pdf PDF
MOD_P00002_SPE2D218D0058.pdf PDF
SPE2D218D0058P00001_SIGNED.pdf PDF
SPE2D218D0058_SIGNED.pdf PDF
Clobetasol_SPE2D218R0018_00002.pdf PDF
SPE2D218R00180001.pdf PDF
SPE2D218R0018.pdf PDF

Notice history

Notice Type Posted
Finasteride Tablets Latest special notice Special Notice
Clobetasol propionate 0. 05% solution Award Award Notice
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity